Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Hoentjen

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Digestive Diseases and Sciences|July 30, 2024
Disparities in Advanced Therapy Initiation for Inflammatory Bowel Disease: Access Comes FirstJesse Siffledeen, Frank Hoentjen
Digestive Diseases and Sciences|October 14, 2011
Infectious proctitis: when to suspect it is not inflammatory bowel diseaseFrank Hoentjen, David T Rubin
Nederlands Tijdschrift Voor Geneeskunde|October 4, 2012
[Probiotics have a limited role in the treatment of inflammatory bowel disease]Levinus A Dieleman, Frank Hoentjen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2022
Confirming Effectiveness of Endoscopic Colon Cancer Screening in Inflammatory Bowel Disease: The Puzzle Remains Unsolved?Maarten Te Groen, Frank Hoentjen
Current Gastroenterology Reports|July 27, 2011
Update on the management of ulcerative colitisFrank Hoentjen, Atsushi Sakuraba, Stephen Hanauer
Digestive Diseases and Sciences|May 4, 2026
Managing Refractory Pouchitis: Which Biologic Is Best?Lisa Laforce-van Lierop, Frank Hoentjen
Alimentary Pharmacology & Therapeutics|March 4, 2022
Editorial: anti-TNF combination therapy for inflammatory bowel disease-one size does not fit allEdo H J Savelkoul, Frank Hoentjen
Alimentary Pharmacology & Therapeutics|November 25, 2025
Editorial: High-Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer-Authors' ReplyMonica E W Derks, Frank Hoentjen
World Journal of Gastroenterology|May 7, 2009
Safety of anti-tumor necrosis factor therapy in inflammatory bowel diseaseFrank Hoentjen, Ad A van Bodegraven
Digestive Diseases and Sciences|November 5, 2025
Incidental Inflammatory Bowel Disease: Is Surveillance and Treatment Needed?Lisa M A van Lierop, Frank Hoentjen
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Digestive Diseases and Sciences|July 30, 2024
Disparities in Advanced Therapy Initiation for Inflammatory Bowel Disease: Access Comes FirstJesse Siffledeen, Frank Hoentjen
Digestive Diseases and Sciences|October 14, 2011
Infectious proctitis: when to suspect it is not inflammatory bowel diseaseFrank Hoentjen, David T Rubin
Nederlands Tijdschrift Voor Geneeskunde|October 4, 2012
[Probiotics have a limited role in the treatment of inflammatory bowel disease]Levinus A Dieleman, Frank Hoentjen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2022
Confirming Effectiveness of Endoscopic Colon Cancer Screening in Inflammatory Bowel Disease: The Puzzle Remains Unsolved?Maarten Te Groen, Frank Hoentjen
Current Gastroenterology Reports|July 27, 2011
Update on the management of ulcerative colitisFrank Hoentjen, Atsushi Sakuraba, Stephen Hanauer
Digestive Diseases and Sciences|May 4, 2026
Managing Refractory Pouchitis: Which Biologic Is Best?Lisa Laforce-van Lierop, Frank Hoentjen
Alimentary Pharmacology & Therapeutics|March 4, 2022
Editorial: anti-TNF combination therapy for inflammatory bowel disease-one size does not fit allEdo H J Savelkoul, Frank Hoentjen
Alimentary Pharmacology & Therapeutics|November 25, 2025
Editorial: High-Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer-Authors' ReplyMonica E W Derks, Frank Hoentjen
World Journal of Gastroenterology|May 7, 2009
Safety of anti-tumor necrosis factor therapy in inflammatory bowel diseaseFrank Hoentjen, Ad A van Bodegraven
Digestive Diseases and Sciences|November 5, 2025
Incidental Inflammatory Bowel Disease: Is Surveillance and Treatment Needed?Lisa M A van Lierop, Frank Hoentjen
Pageof 19